Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Potential Safety Concern for Guillain-Barré Syndrome ID’d for Ad26.COV2.S
Cudetaxestat Gets Orphan Drug Status for Systemic Sclerosis
Rethymic Approved for Pediatric Congenital Athymia
Tavneos Approved for ANCA-Associated Vasculitis
Jakafi Approved for Chronic Graft-vs-Host Disease
Ruzurgi Tablets Recalled Due to Yeast, Mold, Bacterial Contamination
mRNA COVID-19 Vaccines Immunogenic in Immunosuppressed Patients
Abatacept Gets Priority Review for Moderate to Severe Acute Graft vs Host Disease
New Vial Sizes for Bivigam, Nabi-HB Now Available
Aviptadil Gets Orphan Drug Status for Sarcoidosis
Saphnelo Approved for Systemic Lupus Erythematosus
Octagam 10% Approved for Adult Dermatomyositis
Prograf Approved to Prevent Organ Rejection in Lung Transplantation
Rezurock Approved for Chronic Graft-vs-Host Disease
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
Ayvakit Approved for Advanced Systemic Mastocytosis
Belimumab Shows Longer-Term Safety, Efficacy in Lupus Nephritis
Drug-Induced Immunosuppression Examined in US Adults
